disease progression

You have accessRestricted Access
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Fouad T. Chebib and Vicente E. Torres

CJASN November 2018, 13 (11) 1765-1776; DOI: https://doi.org/10.2215/CJN.03960318

Add to Selected Citations
You have accessRestricted Access
Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection
Sara Yee Tartof, Jin-Wen Hsu, Rong Wei, Kevin B. Rubenstein, Haihong Hu, Jean Marie Arduino, Michael Horberg, Stephen F. Derose, Lei Qian and Carla V. Rodriguez

CJASN October 2018, 13 (10) 1471-1478; DOI: https://doi.org/10.2215/CJN.01530218

Add to Selected Citations
You have accessRestricted Access
IgA Nephropathy Susceptibility Loci and Disease Progression
Manman Shi, Yan Ouyang, Mingxin Yang, Meng Yang, Xiaoyan Zhang, Wei Huang, Weiming Wang, Zhaohui Wang, Wen Zhang, Xiaonong Chen, Xiaoxia Pan, Hong Ren, Nan Chen and Jingyuan Xie

CJASN September 2018, 13 (9) 1330-1338; DOI: https://doi.org/10.2215/CJN.13701217

Add to Selected Citations
You have accessRestricted Access
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease
Joshua D. Bundy, Lydia A. Bazzano, Dawei Xie, Janet Cohan, Jacqueline Dolata, Jeffrey C. Fink, Chi-yuan Hsu, Kenneth Jamerson, James Lash, Gail Makos, Susan Steigerwalt, Xue Wang, Katherine T. Mills, Jing Chen, Jiang He and the CRIC Study Investigators

CJASN July 2018, 13 (7) 993-1001; DOI: https://doi.org/10.2215/CJN.11121017

Add to Selected Citations
You have accessRestricted Access
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes
Claire Gerber, Xuan Cai, Jungwha Lee, Timothy Craven, Julia Scialla, Nao Souma, Anand Srivastava, Rupal Mehta, Amanda Paluch, Alexander Hodakowski, Rebecca Frazier, Mercedes R. Carnethon, Myles Selig Wolf and Tamara Isakova

CJASN June 2018, 13 (6) 884-892; DOI: https://doi.org/10.2215/CJN.11871017

Add to Selected Citations
You have accessRestricted Access
Association between Duration of Predialysis Care and Mortality after Dialysis Start
Ping Liu, Robert R. Quinn, Matthew J. Oliver, Paul E. Ronksley, Brenda R. Hemmelgarn, Hude Quan, Swapnil Hiremath, Aminu K. Bello, Peter G. Blake, Amit X. Garg, John Johnson, Mauro Verrelli, James M. Zacharias, Samar Abd ElHafeez, Marcello Tonelli and Pietro Ravani

CJASN June 2018, 13 (6) 893-899; DOI: https://doi.org/10.2215/CJN.11951017

Add to Selected Citations
Open Access
Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease
Hiddo J.L. Heerspink and Vlado Perkovic

CJASN June 2018, 13 (6) 946-948; DOI: https://doi.org/10.2215/CJN.01290118

Add to Selected Citations
You have accessRestricted Access
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease
Joshua D. Bundy, Lydia A. Bazzano, Dawei Xie, Janet Cohan, Jacqueline Dolata, Jeffrey C. Fink, Chi-yuan Hsu, Kenneth Jamerson, James Lash, Gail Makos, Susan Steigerwalt, Xue Wang, Katherine T. Mills, Jing Chen, Jiang He and the CRIC Study Investigators

CJASN June 2018, CJN.11121017; DOI: https://doi.org/10.2215/CJN.11121017

Add to Selected Citations
You have accessRestricted Access
Time-Centered Approach to Understanding Risk Factors for the Progression of CKD
Elaine Ku, Kirsten L. Johansen and Charles E. McCulloch

CJASN May 2018, 13 (5) 693-701; DOI: https://doi.org/10.2215/CJN.10360917

Add to Selected Citations
You have accessRestricted Access
Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients
Milica Bozic, Angels Betriu, Marcelino Bermudez-Lopez, Alberto Ortiz, Elvira Fernandez, Jose M. Valdivielso and on behalf of the NEFRONA investigators

CJASN April 2018, 13 (4) 577-584; DOI: https://doi.org/10.2215/CJN.07980717

Add to Selected Citations

Main menu

User menu

Search

disease progression

Pages

About

Author Information

More information